Jump to content

Page values for "Ibuprofen"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringIbuprofen
brandStringAdvil, Motrin, IBU, Caldolor (IV), NeoProfen (neonatal IV)
structureFile
classesList of String, delimiter: ,[[:Category:NSAIDs|Non-steroidal anti-inflammatory (NSAID non-selective)]] [[:Category:Analgesics|Analgesic]] [[:Category:Antipyretics|Antipyretic]]
mechanismString
usesString'"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"', '"`UNIQ--vote-00000023-QINU`"', '"`UNIQ--vote-00000024-QINU`"', '"`UNIQ--vote-00000025-QINU`"'
starting_doseString200-400 mg PO every 4-6 hours as needed. OTC max 1200 mg/day without provider direction; prescription max 3200 mg/day divided
preparationsStringTablets 200, 400, 600, 800 mg; capsules 200 mg; oral suspension 100 mg/5 mL; chewable tablets 100 mg; injection 100 mg/mL (Caldolor)
fda_maxString3200 mg/day (Rx); 1200 mg/day (OTC, without provider direction)
pill_idText
routesList of String, delimiter: ,Oral intravenous (Caldolor NeoProfen)
onsetString30-60 minutes (oral)
durationString4-6 hours
halflifeString2-4 hours'"`UNIQ--ref-00000026-QINU`"'
bioavailabilityString~80-100% (oral)'"`UNIQ--ref-00000027-QINU`"'
pregnancyStringAvoid from 20 weeks gestation onward per FDA's 2020 expanded NSAID warning (fetal renal dysfunction, oligohydramnios); contraindicated from 30 weeks (risk of premature ductus arteriosus closure)'"`UNIQ--ref-00000028-QINU`"'
legalString[[USLegal:Over-the-counter|OTC]] in the US at ≤200 mg per tablet / ≤1200 mg/day; [[USLegal:Prescription only|Rx-only]] at higher strengths and indications